SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-16-741812
Filing Date
2016-10-19
Accepted
2016-10-19 16:50:37
Documents
11

Document Format Files

Seq Description Document Type Size
1 424B4 d183927d424b4.htm 424B4 2785174
2 GRAPHIC g183927g21w10.jpg GRAPHIC 33374
3 GRAPHIC g183927g28n12.jpg GRAPHIC 47260
4 GRAPHIC g183927g42b53.jpg GRAPHIC 52782
5 GRAPHIC g183927g46v89.jpg GRAPHIC 105238
6 GRAPHIC g183927g50u51.jpg GRAPHIC 42520
7 GRAPHIC g183927g77f17.jpg GRAPHIC 81259
8 GRAPHIC g183927g80c75.jpg GRAPHIC 52173
9 GRAPHIC g183927g84b16.jpg GRAPHIC 34581
10 GRAPHIC g183927g87t50.jpg GRAPHIC 104996
11 GRAPHIC g183927g89g09.jpg GRAPHIC 49389
  Complete submission text file 0001193125-16-741812.txt   3615032
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478
Type: 424B4 | Act: 33 | File No.: 333-213577 | Film No.: 161942913
SIC: 2836 Biological Products, (No Diagnostic Substances)